ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Flagship Pioneering, Inc.
Mirai Bio seeks an experienced ML scientist to design, implement, and deploy novel machine learning approaches that optimize in vivo therapeutic delivery vehicles and accelerate discovery of genomic medicines. The role involves building computational platforms and pipelines to support identification and testing of therapeutic candidates and working cross-functionally with experimental and infrastructure teams. The position supports Mirai’s mission to integrate nanoparticle development with informatics to advance information molecule therapeutics.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Founded
2000
Flagship Pioneering is a venture creation and investment firm that invents, builds, and funds early-stage companies in biotechnology, life sciences, and sustainability. Using an integrated model of in-house science, lab infrastructure, capital, and operational support, it spins out and scales breakthrough ventures — it has helped found more than 100 companies, including high-profile names such as Moderna. Flagship focuses on deep‑science innovation and long‑term partnerships to translate novel discoveries into transformative products for human health and the planet.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Flagship Pioneering, Inc..
individual investors who own 52% along with institutions invested in Seres Therapeutics, Inc. (NASDAQ:MCRB) saw increase in their holdings value last week
Jul 20, 2025
Scientist - AI & ML for Protein and Antibody Engineering
Roche
AI/ML Scientist – Protein Foundation Models
Manifold Bio
AVP of Generative Foundation Models for Biotherapeutics
Eli Lilly and Company
Genomic AI Scientist – Drug Discovery Data Scientist
Eli Lilly and Company
AI Machine Learning Data Analytics Principal Engineer - P4 (Remote)
RTX
Associate Scientist/Scientist I
MiraiBio Group at Hitachi Solutions America
